SWOT Analysis for Teva- Pharmaceutical Industries Ltd. - ADR

30 Day SMA crossing over 200 Day SMA, and current price greater than open
Consistent Highest Return Stocks over Five Years
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over the Quarter (3 Months)
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Increasing profits every quarter for the past four quarters
Increasing profits every quarter for the past 4 quarters
Top Gainers
Stock with Low PE (PE < = 10)
RSI indicating price strength
Volume Shockers
Stocks Outperforming their Industry Price Change in the Quarter

Momentum Trap (DVM)
Companies with High Debt
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Low durability companies
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Companies with Increasing Debt
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Book Value Per Share deteriorating for last 2 years